Suzhou Zelgen Biopharmaceuticals Co.,Ltd. (SHA:688266)
China
· Delayed Price · Currency is CNY 107.90
-5.80 (-5.10%)
Jun 27, 2025, 3:00 PM CST
SHA:688266 Market Cap
SHA:688266 has a market cap or net worth of 30.42 billion as of June 27, 2025. Its market cap has increased by 112.46% in one year.
Market Cap
30.42B
Enterprise Value
29.29B
Revenue
592.35M
Ranking
n/a
PE Ratio
n/a
Stock Price
107.90
Market Cap Chart
Since January 23, 2020, SHA:688266's market cap has increased from 17.90B to 30.42B, an increase of 69.93%. That is a compound annual growth rate of 10.26%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 27, 2025 | 28.56B | 73.17% |
| Dec 31, 2024 | 16.49B | 17.70% |
| Dec 29, 2023 | 14.01B | 40.02% |
| Dec 30, 2022 | 10.01B | -29.08% |
| Dec 31, 2021 | 14.11B | -9.10% |
| Dec 31, 2020 | 15.53B | -13.27% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Jiangsu Hengrui Medicine | 345.12B |
| Shenzhen Mindray Bio-Medical Electronics | 275.14B |
| WuXi AppTec | 189.25B |
| Zhangzhou Pientzehuang Pharmaceutical., | 121.15B |
| Sichuan Biokin Pharmaceutical | 119.30B |
| Aier Eye Hospital Group | 115.08B |
| Shanghai United Imaging Healthcare | 105.85B |
| Yunnan Baiyao Group Co.,Ltd | 100.51B |